Latest news with #HenrySimmons
The Sun
07-07-2025
- Entertainment
- The Sun
Love Island star dumped by millionaire boyfriend AGAIN as friends reveal brutal reason behind split
LOVE Island star Kady McDermott has been dumped by her millionaire boyfriend again – with friends thinking he can make the most of single life during the summer season. The Love Island All Star, who first found fame on series two of the ITV2 favourite, has been with Henry Simmons since September 2024 – though the pair have had a string of make-ups and break-ups since. 6 6 However, after confirming their romance was back on once again in April, insiders have told The Sun Online they have already split, this time with Henry doing the dumping. A source told The Sun Online: 'Henry and Kady have had their ups and downs since they started dating. "Henry called things off again a couple of weeks ago for the summer. Kady's friends are convinced he just does things like this so he can enjoy a single summer. "He's been accused of cheating on her in the past and she took him back - and she'll no doubt give it another go again once he comes crawling back." The source added: "Her friends are worried about her but she's smitten - and loves the lifestyle that comes with dating Henry.' The Sun Online has reached out to Kady's reps for comment. Henry, 25, was a former cast member of Absolutely Ascot, gaining a reputation on the show as a bad boy. He is the heir to a wealthy property developer, and enjoys a lavish lifestyle including multiple luxury getaways. Kady started dating Henry shortly after her split from Ouzy See, who she got together with during a stint in Love Island All Stars. Just three months after he started dating Kady, she made it clear in December that she was on the outs with Henry – even declaring she was "done with men". Kady McDermott's New Romance Unveiled! She publicly accused him of cheating on her by telling her TikTok followers: "I caught two girls leaving his house Saturday morning whilst he was in his boxers. "I'm definitely not the problem." She later added: "No matter how good you are to someone you can't change their bad morals unfortunately." However, by December she was posting pictures in his Ferrari, signalling they were back on. Kady McDermott's Love Life KADY McDermott has split from her reality TV boyfriend Henry Simmons. Here we put her love life under the spotlight. Kady returned to Love Island last year to find a new man and started dating footballer Ouzy See, but they split shortly after leaving the villa. The bikini babe first found fame when she appeared on Love Island in the summer of 2016. It was there she met now ex-boyfriend Scott Thomas, and the pair went on to finish in third place. After leaving the villa, they tried to make ago of it, but split not long after. Kady's next serious boyfriend was when she got together with Towie star Myles Barnett in 2018. They split several times during their rocky romance, and finally confirmed that it was all over in 2021. Despite their on/off relationship, they spent thousands renovating their home into a swish two storey house with six bedrooms. Kady then enjoyed a brief romance with footballer Matty Cash but they also ended up going their separate ways. She started dating the sports star in summer 2022 but the couple struggled to make the relationship work long-term. A source said at the time: 'Kady and Matty had a really good couple of months but decided they weren't right for each other. 'They are still mates and keep in touch, but there's nothing romantic anymore. They had both just got out of long term romances when they got together so might not have been ready.' The Sun exclusively revealed how Kady was dating 30-year-old Londoner Liam Greer for more than a year before returning to Love Island. 6 6 6
The Herald Scotland
29-06-2025
- Health
- The Herald Scotland
Scotland is sleepwalking into a dementia care crisis
In a desperate bid to plug predicted budget gaps, members of Integration Joint Boards (IJBs) across the country are choosing to find millions of pounds of savings from their older people and community care budgets. Unfortunately, this is where the mainstay of community support and dementia-specific services can be found. Among the worst affected areas are care at home, respite and day care services, which provide lifeline support to people who are in a moderate to advanced stage of their illness. Post diagnostic support services are also under pressure in some areas, despite a world-leading commitment that every person diagnosed should receive a minimum of one year's support. To make matters worse, many families are also being hit with significantly increased charges for many forms of community support. Read more: All of this will place an inordinate level of pressure on family carers, while the lack of community support for people with dementia will without doubt accelerate their increased level of need – denying each person the chance to live well with support for a long as possible. It will also place a remarkable strain on other elements of our health and social care system and will be nothing more than a short-term budget balancing saving. We do not need to look too far for evidence to back this up. During the Covid pandemic we witnessed first-hand the significant impact of stopping community services on individuals and their families. Many of these latest decisions have already been made, with no opportunity for those whose lives will be profoundly affected by this slash-and-burn approach to have their views heard. Henry Simmons is concerned over the cutsMost worryingly in recent months, we are aware of several specialised dementia facilities that have been threatened with significant funding cuts or complete closure due to financial pressures, with people finding out these plans with only months, sometimes weeks, to consider alternatives. Scotland is sleepwalking into a dementia care crisis. It is estimated that around 90,000 people in Scotland are living with dementia, and this number is expected to rise significantly in the coming years. As the population ages, the demand for dementia services will inevitably increase, making it essential that we have robust systems in place to support those in need. We believe this highlights an urgent need for a comprehensive review of the current dementia strategy and its main priorities. That's why Alzheimer Scotland has written to all MSPs, MPs and council leaders across the country, as well as to ministers and local government body COSLA calling for urgent action. The impact of these cutbacks on individuals and their families cannot be overstated. In the moderate and advanced stages of dementia, the need for specialist high quality support increases – yet this is where many of the cuts are planned or have been imposed. Carers and family members are being left to shoulder the burden, leading to almost unbearable physical, emotional and financial strain. The lack of adequate support services such as specialised day care and residential respite care exacerbates the challenges faced by those living with dementia and their families. We believe services like day care and post diagnostic support are an essential form of healthcare and should not be treated as disposable extras that can be discarded on a whim whenever budgets are under pressure. It is not right that dementia care is left to a postcode lottery. We are calling for a guaranteed pathway where evidence-based interventions are given to everyone with a dementia diagnosis throughout the progression of their condition – every time, everywhere throughout Scotland. Read more: This postcode lottery must end. Dementia care must be a priority and it must be regarded in the same way as other illnesses such as cancer, chest, heart and stroke – all of which have clear pathways and standards that are consistently enforced across the country. Scotland's dementia strategy must take an immediate and effective lead on this. There should be no doubt what you will be offered as you go through your time living with dementia. It should not be left to local commissioners to make decisions purely based on how much money is left in their budgets. Dementia is a progressive, terminal condition arising from many forms of untreated brain disease. There is no cure and no disease modifying drugs at present. We owe it to every person living with dementia and their families to provide the right care, treatment and support. It is not too late to stop the decimation of community and specific dementia services. Our political and health leaders must act quickly if we are to protect tens of thousands of Scotland's most vulnerable people from these devastating cuts. Henry Simmons is Chief Executive of Alzheimer Scotland
STV News
09-06-2025
- Health
- STV News
Alzheimer's research suffers 'devastating blow' after new drug rejected by NHS
A woman who has Alzheimer's disease has said the progression of research has suffered a 'devastating blow' after a new drug was rejected for use by NHS Scotland. Donanemab delays the onset of dementia and works by targeting a cause of the disease, rather than just treating its symptoms. But the Scottish Medicines Consortium says there isn't enough evidence to prove how well it works. Recently retired Rynagh has lived an enviable life, growing up in Ireland, moving to the US, and attending New York University. Coming to Scotland, she expected to live out the rest of her life in peaceful retirement. Instead, she found out she had dementia. She's now thrown into finding a cure for Alzheimer's – and says the rejection of this drug is a massive blow. 'What would it take to approve a drug for dementia?', she said. 'Because it seems to be a lost in space for people. There aren't annual check-ups or anything like there are with other diseases. So there's no record of decline, which is unusual when you think about how progress is made with other diseases over time. 'Think about polio, leprosy, and cancer. They were known many years ago, but we don't talk about them because of the needs and the cost. 'And I understand that cost is a factor, but the burden on society, even in comparison to those other diseases, is tremendous. Absolutely. And only tremendous. It's not just the individual, it's the community, it's the family. 'It's the cost to the next generation for what they lose out by having to provide that care and not being able to support their own families, immediate families, in the way that they will.' Donanemab works when antibodies are given by infusion into a vein in the arm – they then bind with amyloids in the brain, a protein that builds up in Alzheimer's patients, and leads to cognitive decline. Those antibodies trigger immune cells, which clear the amyloid – and slow down the alzheimer's process. The Scottish Medicines Consortium rejected donanemab for use on the NHS as it said there wasn't 'enough evidence of how well it works.' Meanwhile manufacturer Lilly claims the decision 'does not consider … the clinical efficacy and cost-effectiveness' of the drug. It's left campaigners worried about the future of dementia research. Henry Simmons, chief executive of Alzheimer Scotland, said: 'The process that all drugs go through at present at the both the NHS in Scotland and England is a reasonable process however, we don't think it is a reasonable way to tackle the issues we face in terms of the size and scale of dementia, and what we are calling for is a rethink on that.' There's hope the SMC will reconsider the drug, but in the meantime, Rynagh hopes people living with dementia don't give up – and that awareness of the illness continues to grow. 'Well, when it comes down to it, it is the public', she added. 'And if the public doesn't have the awareness, they won't push. 'You know, like 66% is that about two thirds of people with dementia are women. Women typically are the caregivers, but then they need the care and it becomes this cycle and it is increasing instead of decreasing. 'And also with the population pyramid is kind of changing as well. We know that that the elderly population is getting bigger and that's it's a disaster that you should be able to see. 'It's not that you're seeing one seventh of the iceberg. We're now coming to the point where it's so far above the water, it should be that you can go around us and go through it and disperse it, but are not even talking about it at the level that we need to be talking about it.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
BBC News
10-02-2025
- Health
- BBC News
Six new drugs approved for NHS use in Scotland
Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in Scottish Medicines Consortium (SMC) has given the green light to three new cancer treatments as well as a drug to treat a rare type of epilepsy. Medicine that can help prevent HIV infections has also means the treatments can prescribed by NHS doctors across the a drug which has been shown to slow the progression of Alzheimer's is among those not approved. The SMC, the body which approves drugs for use in the health service, said there was "uncertainty" around the "modest clinical benefit" of the drug UK Medicines and Healthcare products Regulatory Agency (MHRA) has deemed the medication as efficient at slowing Alzheimer's drug is the first Alzheimer's treatment of its kind to be licensed for use in Great Britain but it has not been rolled out in England or Wales either due to the at Alzheimer Scotland said they were "disappointed" by the decision, which chief executive Henry Simmons said was "based on the medicine's cost in relation to the evidence of its clinical benefit".He said: "We remain optimistic that these initial hurdles will be overcome and, after decades of waiting, that new treatments will be approved for NHS use soon." Olaparib - which is also known under the brand name Lynparza - was approved for prescription to adults with breast cancer linked to the BRCA1 gene, or those with mutated HER2-negative advanced breast executive of Breast Cancer Now, Claire Rowney, said: "It's brilliant this targeted treatment has been made available on the NHS in Scotland."Crucially, it offers people living with incurable secondary breast cancer with an altered BRCA gene an additional drug option to help stop their cancer from progressing for longer, so they can continue doing the things that matter most to them."In addition to olaparib, the SMC approved cemiplimab for treating women with recurrent or metastatic cervical cancer, where the cancer has progressed on or after also backed the use of durvalumab as a treatment together with chemotherapy for those patients with newly diagnosed extensive-stage small cell lung cancer. Meanwhile, fenfluramine was approved for use to help treat a serious, rare type of epilepsy called Lennox-Gastaut syndrome, with another drug, cabotegravir approved to help prevent sexually transmitted HIV infections in adults and adolescents who are at high risk of being the SMC backed the use of netarsudil/latanoprost for patients suffering from high pressure in the eye or the eye condition chairman Dr Scott Muir said: "The committee was pleased to be able to accept six new medicines for use by NHS Scotland."Cabotegravir, when used together with safer sex practices may help to reduce the spread of HIV, which is an ongoing priority for the Scottish government."Cemiplimab offers a second line treatment option for patients with advanced cervical cancer, where there are few others."
